Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Cresp Onco 200 Injection

Prescription Icon
Prescription Required

Marketer

Dr Reddy's Laboratories Ltd

Salt Composition

Darbepoetin alfa (200mcg)

Overview Cresp Onco 200 Injection

Cresp Onco 200 Injection treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves stimulating red blood cell production within the bone marrow. This medication requires careful administration due to potential serious adverse effects; therefore, treatment should be overseen by a qualified specialist. Strict adherence to the physician's instructions is crucial. Administration occurs under direct medical supervision. Frequently reported side effects include abdominal discomfort, elevated blood pressure, skin rashes, injection site pain, dyspnea, coughing, and peripheral swelling. Report symptoms of significantly elevated blood pressure, such as intense headache, visual disturbances, nausea, vomiting, or convulsions, to your doctor immediately. Regular blood tests to monitor electrolyte (e.g., potassium) levels, hemoglobin, and blood cell counts are typically performed. Discontinue use and seek medical advice if shortness of breath or a skin rash develops. Prior to initiating Cresp Onco 200 Injection, inform your doctor of any pre-existing heart conditions, hypertension, seizure history, or stroke history. Pregnant, breastfeeding, or intending to become pregnant or breastfeed individuals must consult their physician regarding its safety.

Uses of Cresp Onco 200 Injection

Managing anemia associated with chronic kidney disease | Addressing anemia resulting from cancer chemotherapy

Major Benefits of Cresp Onco 200 Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Cresp Onco 200 Injection:

  • Abdominal pain
  • High blood pressure
  • Rash
  • Injection site pain
  • Breathlessness
  • Cough
  • Peripheral edema
  • Procedural hypotension (low blood pressure)
  • Convulsion
  • Thromboembolism

How to use Cresp Onco 200 Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Cresp Onco 200 Injection works:

Cresp Onco 200 Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by prompting increased red blood cell synthesis within the bone marrow, the blood cell-producing tissue inside bones.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol with Cresp Onco 200 Injection is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Cresp Onco 200 Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the treatment's advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Cresp Onco 200 Injection while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Cresp Onco 200 Injection.

KidneyKidneySAFE IF PRESCRIBED

Cresp Onco 200 Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.

LiverLiverCAUTION

For individuals with hepatic impairment, administering Cresp Onco 200 Injection requires careful consideration. Dosage modification of Cresp Onco 200 Injection may be necessary. Physician consultation is advised.

What if you forget to take Cresp Onco 200 Injection :

Should you forget a Cresp Onco 200 Injection, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Cresp Onco 200 Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP
Behavioral Class Erythropoietin-stimulating drug

FAQs on Cresp Onco 200 Injection

Within 2 to 6 weeks of beginning Cresp Onco 200 Injection, you should see a rise in your red blood cell count (hemoglobin levels). Consult your doctor with any questions.
Cresp Onco 200 Injection carries significant risk, including potentially fatal side effects. Expert medical supervision by a physician experienced with this injection is crucial. Adhere strictly to all prescribed instructions.
Cresp Onco 200 Injection may be ineffective if you have iron, folic acid, or vitamin B12 deficiencies; address these deficiencies before treatment. Other factors impacting treatment response include bleeding, infections, inflammation, and bone marrow fibrosis. Consult your doctor for advice.
Cresp Onco 200 Injection treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects in children are comparable to those in adults. Consult your doctor for any concerns.
Cresp Onco 200 Injection can influence blood pressure. Blood pressure monitoring is crucial during initial treatment; patients with hypertension should manage their condition accordingly. The injection may be discontinued if blood pressure remains unmanaged.
Cresp Onco 200 Injection should only be administered under a doctor's prescription. Its use is contraindicated for individuals with uncontrolled hypertension, a history of pure red cell aplasia (PRCA) triggered by erythropoietin medications (including Cresp Onco 200 Injection), or a history of serious allergic reactions to this drug.
Cresp Onco 200 Injection
9,544
MRP 11,627
17% off